These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32339497)

  • 1. Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder.
    Masuda N; Murakami K; Kita Y; Hamada A; Kamada M; Teramoto Y; Sakatani T; Matsumoto K; Sano T; Saito R; Okuno Y; Ogawa O; Kobayashi T
    Am J Pathol; 2020 Aug; 190(8):1752-1762. PubMed ID: 32339497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.
    Fantini D; Glaser AP; Rimar KJ; Wang Y; Schipma M; Varghese N; Rademaker A; Behdad A; Yellapa A; Yu Y; Sze CC; Wang L; Zhao Z; Crawford SE; Hu D; Licht JD; Collings CK; Bartom E; Theodorescu D; Shilatifard A; Meeks JJ
    Oncogene; 2018 Apr; 37(14):1911-1925. PubMed ID: 29367767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice.
    Degoricija M; Korac-Prlic J; Vilovic K; Ivanisevic T; Haupt B; Palada V; Petkovic M; Karaman I; Terzic J
    J Transl Med; 2019 Nov; 17(1):394. PubMed ID: 31779626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancers arise from distinct urothelial sub-populations.
    Van Batavia J; Yamany T; Molotkov A; Dan H; Mansukhani M; Batourina E; Schneider K; Oyon D; Dunlop M; Wu XR; Cordon-Cardo C; Mendelsohn C
    Nat Cell Biol; 2014 Oct; 16(10):982-91, 1-5. PubMed ID: 25218638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
    Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
    Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.
    Yang J; Platt LT; Maity B; Ahlers KE; Luo Z; Lin Z; Chakravarti B; Ibeawuchi SR; Askeland RW; Bondaruk J; Czerniak BA; Fisher RA
    Oncotarget; 2016 Oct; 7(43):69159-69172. PubMed ID: 27713144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.
    Oda S; Fujisawa M; Chunning L; Ito T; Yamaguchi T; Yoshimura T; Matsukawa A
    PLoS One; 2021; 16(11):e0254289. PubMed ID: 34818323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.
    Rose M; Maurer A; Wirtz J; Bleilevens A; Waldmann T; Wenz M; Eyll M; Geelvink M; Gereitzig M; Rüchel N; Denecke B; Eltze E; Herrmann E; Toma M; Horst D; Grimm T; Denzinger S; Ecke T; Vögeli TA; Knuechel R; Maurer J; Gaisa NT
    Oncogene; 2020 Oct; 39(44):6856-6870. PubMed ID: 32978523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.
    Shi MJ; Fontugne J; Moreno-Vega A; Meng XY; Groeneveld C; Dufour F; Kamoun A; Viborg Lindskrog S; Cabel L; Krucker C; Rapinat A; Dunois-Larde C; Lepage ML; Chapeaublanc E; Levrel O; Dixon V; Lebret T; Almeida A; De Reynies A; Rochel N; Dyrskjøt L; Allory Y; Radvanyi F; Bernard-Pierrot I
    Eur Urol; 2023 Jan; 83(1):70-81. PubMed ID: 36273937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
    Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
    Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.
    Cao L; Zhou XD; Sens MA; Garrett SH; Zheng Y; Dunlevy JR; Sens DA; Somji S
    J Appl Toxicol; 2010 Jul; 30(5):416-30. PubMed ID: 20186695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of bladder cancer subtypes in neurogenic bladder tumors.
    Manach Q; Cussenot O; Rouprêt M; Gamé X; Chartier-Kastler E; Reus C; Camparo P; Compérat E; Phé V
    Can J Urol; 2018 Feb; 25(1):9161-9167. PubMed ID: 29524970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.
    Shin K; Lim A; Odegaard JI; Honeycutt JD; Kawano S; Hsieh MH; Beachy PA
    Nat Cell Biol; 2014 May; 16(5):469-78. PubMed ID: 24747439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BBN-driven urinary bladder cancer mouse model.
    Korac-Prlic J; Degoricija M; Vilović K; Vujević S; Terzić J
    Methods Cell Biol; 2021; 163():77-92. PubMed ID: 33785170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.
    Wang L; Smith BA; Balanis NG; Tsai BL; Nguyen K; Cheng MW; Obusan MB; Esedebe FN; Patel SJ; Zhang H; Clark PM; Sisk AE; Said JW; Huang J; Graeber TG; Witte ON; Chin AI; Park JW
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):563-572. PubMed ID: 31871155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible rare involvement of O6-methylguanine formation as a significant mutational factor in mouse urinary bladder carcinogenesis models.
    Chen T; Yamamoto S; Kitano M; Murai T; Wanibuchi H; Matsukuma S; Nakatsuru Y; Ishikawa T; Fukushima S
    Teratog Carcinog Mutagen; 1998; 18(3):101-10. PubMed ID: 9728794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.